Youcare Pharmaceutical Group Co. Ltd. A (688658) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Youcare Pharmaceutical Group Co. Ltd. A (688658) has a cash flow conversion efficiency ratio of 0.051x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥173.51 Million ≈ $25.39 Million USD) by net assets (CN¥3.43 Billion ≈ $502.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Youcare Pharmaceutical Group Co. Ltd. A stock valuation for the company's overall valuation and market capitalisation.
Youcare Pharmaceutical Group Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Youcare Pharmaceutical Group Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Youcare Pharmaceutical Group Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Youcare Pharmaceutical Group Co. Ltd. A ranked by their cash flow conversion efficiency. Explore cash flow quality index of Youcare Pharmaceutical Group Co. Ltd. A to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TRANSFORMERS AND RECTIFIERS INDIA
NSE:TARIL
|
-0.019x |
|
Changzhou Tronly New Electronic Materials Co Ltd
SHE:300429
|
0.043x |
|
Yubico AB
ST:YUBICO
|
0.075x |
|
NCC Limited
NSE:NCC
|
-0.167x |
|
Amerigo Resources Ltd.
TO:ARG
|
0.111x |
|
Hubei Huitian New Materials
SHE:300041
|
0.037x |
|
Shandong Ruifeng Chemical Co Ltd
SHE:300243
|
-0.005x |
|
Wutong Holding Group Co Ltd
SHE:300292
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)
The table below shows the annual cash flow conversion efficiency of Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025. View 688658 share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥3.43 Billion ≈ $502.48 Million |
CN¥344.00 Million ≈ $50.34 Million |
0.100x | -18.05% |
| 2024-12-31 | CN¥3.58 Billion ≈ $524.59 Million |
CN¥438.24 Million ≈ $64.13 Million |
0.122x | -44.01% |
| 2023-12-31 | CN¥3.60 Billion ≈ $526.45 Million |
CN¥785.49 Million ≈ $114.94 Million |
0.218x | +820.23% |
| 2022-12-31 | CN¥4.00 Billion ≈ $584.90 Million |
CN¥-121.17 Million ≈ $-17.73 Million |
-0.030x | -123.11% |
| 2021-12-31 | CN¥3.93 Billion ≈ $574.66 Million |
CN¥515.24 Million ≈ $75.40 Million |
0.131x | -32.57% |
| 2020-12-31 | CN¥3.59 Billion ≈ $524.73 Million |
CN¥697.66 Million ≈ $102.09 Million |
0.195x | -32.65% |
| 2019-12-31 | CN¥1.12 Billion ≈ $164.59 Million |
CN¥324.94 Million ≈ $47.55 Million |
0.289x | +26.35% |
| 2018-12-31 | CN¥842.76 Million ≈ $123.32 Million |
CN¥192.70 Million ≈ $28.20 Million |
0.229x | -24.22% |
| 2017-12-31 | CN¥711.86 Million ≈ $104.17 Million |
CN¥214.81 Million ≈ $31.43 Million |
0.302x | -- |
About Youcare Pharmaceutical Group Co. Ltd. A
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder injection, pills, tablets, capsules, ointments, creams, granules, etc. The company provides drugs in various categories, including covering cardio-cerebrovascular, antivirals, central… Read more